Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

»Der har været en periode, hvor vi skulle kalde vores produktionsfolk ind for at producere lidt ekstra eller lave nogle ...

Wegovy and Zepbound — are cutting prices to make the medications more affordable for people without insurance.

Company of China, Ltd. ("Ping An" or the "Group", HKEx: 2318 / 82318; SSE: 601318) took top spot in the Brand Finance Insurance 100 2025 ranking, for the ninth year in a row, boasting a brand value of ...

Pharma brands achieved the most impressions from ABC and saw a year-over-year increase in impressions from cable channels like Fox News, CNN and MSNBC.

European shares were mostly lower on Thursday, after the White House threatened to place a 2005 tariff on EU wine, champagne and spirits in response to the bloc's own retaliatory measures.

In the latest research, scientists from Canada tracked nearly 3,000 Americans who used either semaglutide, the active drug in ...

DMEGC released its 2024 annual report which reveals that the company achieved annual revenue of ?2.4 billion, with a net profit attributable to the parent company of ?238 million, marking a slight ...

Novo Nordisk (NVO) stock rebounds after Kepler Cheuvreux upgrades to Buy following a 42% stock drop over the past year. Read ...

Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...

The Novo Nordisk Foundation and University of Copenhagen researchers have backtracked over a project to redefine how the ...